Weitere antivirale Pyrimidin-Nukleosiden
Pyrimidine 4 min -thionucleosides of the formula (I) where B is a pyrimidine base; and either (a) R is hydrogen and R is hydroxy or fluoro, or (b) R is hydroxy and R is hydrogen, hydroxy or fluoro, or (c) R is fluoro and R is hydrogen or hydroxy, or (d) R and R together form a carbon-carbon bond; an...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pyrimidine 4 min -thionucleosides of the formula (I) where B is a pyrimidine base; and either (a) R is hydrogen and R is hydroxy or fluoro, or (b) R is hydroxy and R is hydrogen, hydroxy or fluoro, or (c) R is fluoro and R is hydrogen or hydroxy, or (d) R and R together form a carbon-carbon bond; and physiologically functional derivatives thereof and processes for their production. Preferably, the base B is of the formula (II) wherein Y is hydroxy or amino, monoalkylamino or dialkylamino; and X is halogen, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano or nitro. The compounds are useful in the treatment of viral infections. |
---|